MannKind to Present at the H.C. Wainwright Global Life Scien
Apr 2, 2019 5:03:58 GMT -5
sportsrancho, esstan2001, and 8 more like this
Post by kite on Apr 2, 2019 5:03:58 GMT -5
www.globenewswire.com/news-release/2019/04/02/1794910/0/en/MannKind-to-Present-at-the-H-C-Wainwright-Global-Life-Sciences-Conference.html
WESTLAKE VILLAGE, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension, announced today that it will be featured as a presenting company at the H.C. Wainwright Global Life Sciences Conference at 12:10 PM (CET) on April 8, 2019. The conference is being held at the Grosvenor House in London, UK.
Michael Castagna, Chief Executive Officer, of MannKind Corporation, will provide an overview of the Company's business during the live presentation and will participate in one-on-one meetings with investors who are registered to attend the conference.
If you are an institutional investor, and would like to attend the Company’s presentation, please click on the following link (www.hcwevents.com ) to register for the conference. Once your registration is confirmed, you will be prompted to log into the conference website to request a one-on-one meeting with the Company.
The presentation will be webcast live. To access the webcast, please visit www.hcwevents.com. Interested parties can also access a link to the live webcast of the presentation from the News & Events section of the Company's website at www.mannkindcorp.com. The webcast replay will remain available for 14 days following the live presentation.
WESTLAKE VILLAGE, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension, announced today that it will be featured as a presenting company at the H.C. Wainwright Global Life Sciences Conference at 12:10 PM (CET) on April 8, 2019. The conference is being held at the Grosvenor House in London, UK.
Michael Castagna, Chief Executive Officer, of MannKind Corporation, will provide an overview of the Company's business during the live presentation and will participate in one-on-one meetings with investors who are registered to attend the conference.
If you are an institutional investor, and would like to attend the Company’s presentation, please click on the following link (www.hcwevents.com ) to register for the conference. Once your registration is confirmed, you will be prompted to log into the conference website to request a one-on-one meeting with the Company.
The presentation will be webcast live. To access the webcast, please visit www.hcwevents.com. Interested parties can also access a link to the live webcast of the presentation from the News & Events section of the Company's website at www.mannkindcorp.com. The webcast replay will remain available for 14 days following the live presentation.
